“The effect of prophylactic high dose N-acetylcysteine for the prevention of contrast induced AKI in patients with CKD (stage 3 and stage 4)”, J. Dhaka Natl. Med. Coll. Hosp., vol. 24, no. 1, pp. 11–17, Mar. 2018, doi: 10.3329/jdnmch.v24i1.80033.